INSIGHTEC’s MR guided Focused Ultrasound technology (Exablate MRgFUS) can treat painful bone metastases, providing prompt pain relief and significant improvement in patients’ quality of life. This non-invasive, non-ionizing treatment uses focused ultrasound waves, guided by magnetic resonance imaging (MRI), to ablate the target, ensuring an effective, accurate treatment: • High intensity focused ultrasound generates 65-85oC of heat at the ablated targeted tissue. • Magnetic resonance imaging system (MRI) allows the physician to identify and targeted Bone Mets while providing temperature monitoring the surrounding areas in real time.

View our treatment centers

How it works

MRgFUS Treatment of Painful Bone Metastases

FDA LABELING

Pain palliation of metastatic bone cancer in patients 18 years of age or older who are suffering from bone pain due to metastatic diseases and who are failures of standard radiation therapy, or not candidates for, or refused radiation therapy. The bone tumor to be treated must be visible on a non-contrast MR and device accessible.

    • Pain Palliation of Bone Mets
      Read More close

Why Insightec Oncology?

  • Clinical Benefits

    Treating painful bone metastases in a non-ionizing, non-invasive way, presenting minimal complications, achieved in a single-session procedure. May be done simultaneously with chemotherapy; no contradiction.

  • Patient Value

    Treating painful bone metastases, resulting in pain relief within days and minimal recovery time. May reduce use of opioid analgesics and improve quality of life.

  • Operational efficiency

    No hospitalization is required. Medical facilities can expand their range of services and diversify the use of the MR suite.

TREATMENT CENTERS

Please fill all the following details and we will get in touch with you (* Required)

agreement Error

Thank You!

Thank you for contacting us! We will get back to you shortly.

Thank You!

This site is brought to you by INSIGHTEC, © 2017 Insightec Ltd. All rights reserved

NGSoft logo